Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Gossamer Bio Inc.

    NASDAQ: GOSS · Real-Time Price · USD
    1.30
    -0.06 (-4.41%)
    At close: Jun 26, 2025, 3:59 PM
    1.31
    0.38%
    Pre-market: Jun 27, 2025, 07:16 AM EDT

    Gossamer Bio Statistics

    Share Statistics

    Gossamer Bio has 227.3M shares outstanding. The number of shares has increased by 0.44% in one year.

    Shares Outstanding

    n/a
    		 227.3M

    Shares Change (YoY)

    n/a
    		 0.44%

    Shares Change (QoQ)

    n/a
    		 0.27%

    Owned by Institutions (%)

    n/a
    		 75.71%

    Shares Floating

    n/a
    		 182.66M

    Failed to Deliver (FTD) Shares

    n/a
    		 5

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 11.08M, so 4.88% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 11.08M

    Short % of Shares Out

    n/a
    		 4.88%

    Short % of Float

    n/a
    		 5.19%

    Short Ratio (days to cover)

    n/a
    		 6.64

    Valuation Ratios

    The PE ratio is -3.62 and the forward PE ratio is -2.87. Gossamer Bio's PEG ratio is 0.05.

    PE Ratio

    n/a
    		 -3.62

    Forward PE

    n/a
    		 -2.87

    PS Ratio

    n/a
    		 1.78

    Forward PS

    n/a
    		 0.8

    PB Ratio

    n/a
    		 6.94

    P/FCF Ratio

    n/a
    		 -59.01

    PEG Ratio

    n/a
    		 0.05
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Gossamer Bio.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 6.88, with a Debt / Equity ratio of 6.88.

    Current Ratio

    n/a
    		 6.88

    Quick Ratio

    n/a
    		 6.88

    Debt / Equity

    n/a
    		 6.88

    Debt / EBITDA

    n/a
    		 -5.08

    Debt / FCF

    n/a
    		 -58.5

    Interest Coverage

    n/a
    		 -5.2

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $796,534.72

    Profits Per Employee

    n/a
    		 $-392,555.56

    Employee Count

    n/a
    		 144

    Asset Turnover

    n/a
    		 0.36

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 893K

    Effective Tax Rate

    n/a
    		 -1.61%

    Stock Price Statistics

    The stock price has increased by 36.54% in the last 52 weeks. The beta is 1.85, so Gossamer Bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.85

    52-Week Price Change

    n/a
    		 36.54%

    50-Day Moving Average

    n/a
    		 1.13

    200-Day Moving Average

    n/a
    		 1.02

    Relative Strength Index (RSI)

    n/a
    		 54.08

    Average Volume (20 Days)

    n/a
    		 1,541,996

    Income Statement

    In the last 12 months, Gossamer Bio had revenue of 114.7M and earned -56.53M in profits. Earnings per share was -0.25.

    Revenue

    n/a
    		 114.7M

    Gross Profit

    n/a
    		 114.7M

    Operating Income

    n/a
    		 -59.92M

    Net Income

    n/a
    		 -56.53M

    EBITDA

    n/a
    		 -39.97M

    EBIT

    n/a
    		 -44.12M

    Earnings Per Share (EPS)

    n/a
    		 -0.25
    Full Income Statement

    Balance Sheet

    The company has 46.07M in cash and 202.88M in debt, giving a net cash position of -156.81M.

    Cash & Cash Equivalents

    n/a
    		 46.07M

    Total Debt

    n/a
    		 202.88M

    Net Cash

    n/a
    		 -156.81M

    Retained Earnings

    n/a
    		 -1.27B

    Total Assets

    n/a
    		 280.59M

    Working Capital

    n/a
    		 227.25M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -3.47M and capital expenditures 0, giving a free cash flow of -3.47M.

    Operating Cash Flow

    n/a
    		 -3.47M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -3.47M

    FCF Per Share

    n/a
    		 -0.02
    Full Cash Flow Statement

    Margins

    Gross margin is 100%, with operating and profit margins of -52.24% and -49.28%.

    Gross Margin

    n/a
    		 100%

    Operating Margin

    n/a
    		 -52.24%

    Pretax Margin

    n/a
    		 -48.5%

    Profit Margin

    n/a
    		 -49.28%

    EBITDA Margin

    n/a
    		 -34.84%

    EBIT Margin

    n/a
    		 -52.24%

    FCF Margin

    n/a
    		 -3.02%

    Dividends & Yields

    GOSS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for GOSS is $8, which is 515.4% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $8

    Price Target Difference

    n/a
    		 515.4%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -5.01

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist